News
12-28-2009, 10:00 PM
Compugen Ltd. announced today the discovery and experimental validation of CGEN-671, a new drug target for multiple epithelial tumors.
More... (http://www.news-medical.net/news/20091228/CGEN-671-a-new-drug-target-for-multiple-epithelial-tumors-discovered-by-Compugen.aspx)
More... (http://www.news-medical.net/news/20091228/CGEN-671-a-new-drug-target-for-multiple-epithelial-tumors-discovered-by-Compugen.aspx)